Cell & Gene Therapy Symposium
Charting the Future of CAR-T Access
Since the first CAR T-cell therapy for cancer was approved in 2017, the field has expanded with new options and indications. Yet the market remains underpenetrated, and too many patients still face obstacles to access.
This collaborative workshop will convene stakeholders to better understand today’s most pressing barriers and work toward practical solutions. Findings from the symposium will be shared broadly to help move the field forward.
Patient Access
Exploring the obstacles that can delay or prevent patients from receiving innovative cell therapies.
Reimbursement
Addressing public- and private-sector reimbursement challenges across the care landscape.
Regulatory Considerations
Examining regulatory barriers and opportunities to support responsible progress in the field.
Sponsorship Opportunities
Promote your brand and build your network by sponsoring or exhibiting at the Cell & Gene Therapy Symposium!
Sponsorship and exhibitor benefits include:
- Prominent brand placement
- Priority registration
- Access to VIP hotel room block
- Intimate meeting format
- Powerful networking opportunities
- and more!
Don’t miss your chance to interact with key stakeholders and decision makers from across the cell and gene therapy ecosystem.
Connect with Shannon Sweeney, Executive Vice President of Sales, to explore the full range of sponsorship and exhibitor packages available.
Register Today
Join us on October 21, 2026 at the New York Athletic Club in New York, NY
